Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
2.890
+0.110 (3.96%)
At close: Oct 24, 2025, 4:00 PM EDT
2.800
-0.090 (-3.11%)
After-hours: Oct 24, 2025, 7:59 PM EDT
Metagenomi Market Cap
Metagenomi has a market cap or net worth of $108.47 million as of October 24, 2025. Its market cap has increased by 48.62% in one year.
Market Cap
108.47M
Enterprise Value
-53.53M
1-Year Change
48.62%
Ranking
Category
Stock Price
$2.89
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi's market cap has decreased from $562.92M to $108.47M, a decrease of -80.73%. That is a compound annual growth rate of -61.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 108.47M | -19.71% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.35B |
| Johnson & Johnson | 464.66B |
| AbbVie | 403.98B |
| UnitedHealth Group | 327.39B |
| AstraZeneca | 259.95B |
| Novartis AG | 255.24B |
| Novo Nordisk | 237.27B |
| Abbott Laboratories | 222.69B |